Hyperprogressive disease during anti-PD-1 (PDCD1) / PD-L1 (CD274) therapy: A systematic review and meta-analysis
- Jong Yeob Kim
- , Keum Hwa Lee
- , Jeonghyun Kang
- , Edith Borcoman
- , Esma Saada-Bouzid
- , Andreas Kronbichler
- , Sung Hwi Hong
- , Leandro Fórnias Machado de Rezende
- , Shuji Ogino
- , Nana Keum
- , Mingyang Song
- , Claudio Luchini
- , Hans J. van der Vliet
- , Jae Il Shin
- , Gabriele Gamerith
- Yonsei University
- Institut Curie
- Université Côte d'Azur
- Innsbruck Medical University
- Harvard University
- Universidade Federal de São Paulo
- Broad Institute
- Dana-Farber Harvard Cancer Center
- Brigham and Women’s Hospital
- Massachusetts General Hospital
- University of Verona
- Vrije Universiteit Amsterdam
- Tyrolean Cancer Research Institute
Research output: Contribution to journal › Article › peer-review
90
Scopus
citations